TCM Biotech International Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	682.4	666.53	969.62	802.42	702.05	737.08
Revenue Growth (YoY)	-8.63%	-31.26%	20.84%	14.30%	-4.75%	29.62%
Cost of Revenue	361.66	339.22	489.45	353.93	343.33	368.15
Gross Profit	320.74	327.31	480.17	448.49	358.72	368.92
Selling, General & Admin	209.27	224.09	380.38	340.9	276.14	259.59
Research & Development	90.79	93.22	77.46	81.8	80.45	71.53
Operating Expenses	298.3	316.61	457.84	423.19	356.59	331.87
Operating Income	22.44	10.7	22.33	25.3	2.13	37.05
Interest Expense	-0.9	-1.61	-2.77	-2.39	-1.97	-1.95
Interest & Investment Income	5.79	4.69	1.55	0.14	0.04	0.07
Currency Exchange Gain (Loss)	-	-	-	0.01	0.44	-0.55
Other Non Operating Income (Expenses)	-3.47	11.24	0.93	0.07	0.71	0.16
EBT Excluding Unusual Items	23.86	25.02	22.03	23.13	1.35	34.78
Gain (Loss) on Sale of Assets	-	-	-	-	0.91	1.35
Pretax Income	23.86	25.02	22.03	23.13	2.26	36.13
Income Tax Expense	2.78	4.01	3.46	4.86	0.38	10.59
Net Income	21.08	21.01	18.57	18.27	1.87	25.54
Net Income to Common	21.08	21.01	18.57	18.27	1.87	25.54
Net Income Growth	-26.29%	13.11%	1.69%	875.17%	-92.67%	292.17%
Shares Outstanding (Basic)	59	59	53	49	49	48
Shares Outstanding (Diluted)	59	59	53	49	49	48
Shares Change (YoY)	0.87%	11.37%	8.03%	0.89%	0.42%	-0.03%
EPS (Basic)	0.36	0.36	0.35	0.37	0.04	0.53
EPS (Diluted)	0.36	0.36	0.35	0.37	0.04	0.52
EPS Growth	-26.93%	1.66%	-5.41%	861.49%	-92.66%	289.82%
Free Cash Flow	36.37	159.42	-41.51	48.46	11.19	71.96
Free Cash Flow Per Share	0.62	2.70	-0.78	0.99	0.23	1.49
Dividend Per Share	0.350	0.350	0.285	0.033	-	0.349
Dividend Growth	22.81%	22.81%	763.64%	-	-	-10.00%
Gross Margin	47.00%	49.11%	49.52%	55.89%	51.10%	50.05%
Operating Margin	3.29%	1.60%	2.30%	3.15%	0.30%	5.03%
Profit Margin	3.09%	3.15%	1.92%	2.28%	0.27%	3.46%
Free Cash Flow Margin	5.33%	23.92%	-4.28%	6.04%	1.59%	9.76%
EBITDA	40.6	28.61	39.52	40.86	16.42	50.35
EBITDA Margin	5.95%	4.29%	4.08%	5.09%	2.34%	6.83%
D&A For EBITDA	18.16	17.92	17.19	15.56	14.29	13.3
EBIT	22.44	10.7	22.33	25.3	2.13	37.05
EBIT Margin	3.29%	1.60%	2.30%	3.15%	0.30%	5.03%
Effective Tax Rate	11.65%	16.02%	15.70%	21.02%	17.01%	29.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.